CVS
CVS HEALTH CORPORATION
RETAIL-DRUG STORES AND PROPRIETARY STORES
CVS HEALTH (CVS) Stock: Buy, Sell, or Hold?
$89.79
+0.27 (+0.30%)
▲
5d:
+10.4%
30d:
-0.66%
90d:
-7.59%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (83%)
Quality Score
63/100
Position
FAIR
30-Day Fair Range
$85.63 – $92.82
Position: FAIR
Forward P/E & Valuation
10.4x
FAIR
vs 10.8x historical avg
Wall Street Target
$110.32
+22.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$77.33 / $91.95
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: CVS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
CVS is flagged by 1 backtest-validated scanner today
SPY Bullish (stocks from this scanner have beaten SPY by a median 0.37% over the next 20 trading days; CVS has been on it 3 days). Backtested on 8 months of scanner history vs the S&P 500, as of 2026-11-12.
See all of today's Best Signals in the free scanner →Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 10, 2026 at $88.06 · last confirmed Nov 12, 2026
Strength: 5.1/10
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$116.34
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$72.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $89.79, which is considered fair relative to its 30-day fair value range of $85.63 to $92.82. The stock's valuation (Forward PE: 10.4) is in line with its historical norms (10.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 188.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CVS is in a strong downtrend. The price is approaching resistance at $91.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $110.32 (+22.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CVS is in a strong downtrend. The price is approaching resistance at $91.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $110.32 (+22.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$85.63 -
$92.82
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.3%
Trading Range & Key Levels
30-Day Trading Range
$85.63 -
$92.82
Current vs Trading Range
FAIR
Support Level
$77.33
Resistance Level
$91.95
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (71/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.9% below Wall St target ($110.32)
- BULLISH: Bottoming setup score 71/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
10.36
Wall Street Target
$110.32
(+22.9%)
Revenue Growth (YoY)
5.4%
Earnings Growth (YoY)
188.8%
Profit Margin
2.6%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
10.4 vs 10.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$88.71
(-1%)
2-Year Target
$87.65
(-2%)
3-Year Target
$86.60
(-4%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$90.25
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 4.9%)
$198.56
(+121%)
Base:
(SPY PE: 10.4, Growth: 4.9%)
$103.60
(+15%)
Bear:
(PE: 8.8, Growth: 4.9%)
$88.06
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 10.40 | Current EPS (TTM): $8.61
Bull Case
$99.10
(+10%)
Analyst growth 0.6%, PE expands to 11.4
Base Case
$90.09
(+0%)
Market implied 0.6%, PE stable at 10.4
Bear Case
$60.87
(-32%)
Severe decline -20.0%, PE contracts to 8.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.4 to 10.8
Stabilization Target:
$93.58
(+4.2%)
PE Expansion Potential:
+4.2%
Share CVS Analysis
Share this live CVS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CVS)
Bearish
10 Retail Mentions
Reddit / WSB Comments
9
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
CVS Health management expects the Health Services segment, which is the largest by revenue, to have its lowest earnings point in 2027 with adjusted operating income at least $7 billion. Headwinds include a decline in the 340B business and a less robust selling season.
Key Retail Themes:
CVS Health's earnings outlook for Health Services segment
Impact of headwinds on the segment's earnings
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:56 PM ET
Data refreshes hourly during market hours. Next update: 9:56 PM
Data refreshes hourly during market hours. Next update: 9:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$477 | 59 HOLD |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$482 | 64 BUY |
|
CI
The Cigna Group |
STRONG BUY
24 analysts |
$342 | 47 HOLD |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 44 HOLD |
|
CNC
Centene Corp |
HOLD
21 analysts |
$75 | 47 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CVS Research Pages
